Guidelines for the first line management of classical Hodgkin lymphoma
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Guidelines for the first line management of classical Hodgkin lymphoma
Authors
Keywords
-
Journal
BRITISH JOURNAL OF HAEMATOLOGY
Volume 166, Issue 1, Pages 34-49
Publisher
Wiley
Online
2014-04-09
DOI
10.1111/bjh.12878
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and Stanford V in older Hodgkin lymphoma patients: a comprehensive analysis from the North American intergroup trial E2496
- (2013) Andrew M. Evens et al. BRITISH JOURNAL OF HAEMATOLOGY
- Modern Radiation Therapy for Hodgkin Lymphoma: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group (ILROG)
- (2013) Lena Specht et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- ABVD in Older Patients With Early-Stage Hodgkin Lymphoma Treated Within the German Hodgkin Study Group HD10 and HD11 Trials
- (2013) Boris Böll et al. JOURNAL OF CLINICAL ONCOLOGY
- Fertility Preservation for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
- (2013) Alison W. Loren et al. JOURNAL OF CLINICAL ONCOLOGY
- International Validation Study for Interim PET in ABVD-Treated, Advanced-Stage Hodgkin Lymphoma: Interpretation Criteria and Concordance Rate Among Reviewers
- (2013) A. Biggi et al. JOURNAL OF NUCLEAR MEDICINE
- Computed tomography and positron emission tomography/computed tomography surveillance after combined modality treatment of supradiaphragmatic Hodgkin lymphoma: a clinical and economic perspective
- (2013) Vatsal Patel et al. LEUKEMIA & LYMPHOMA
- Goserelin with chemotherapy to preserve ovarian function in pre-menopausal women with early breast cancer: menstruation and pregnancy outcomes
- (2012) M. Wong et al. ANNALS OF ONCOLOGY
- Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial
- (2012) K. Behringer et al. ANNALS OF ONCOLOGY
- Evaluation of treatment outcome in 175 patients with Hodgkin lymphoma aged 60 years or over: the SHIELD study
- (2012) S. J. Proctor et al. BLOOD
- Recommendations for the Use of Radiotherapy in Nodal Lymphoma
- (2012) P.J. Hoskin et al. CLINICAL ONCOLOGY
- Hodgkin lymphoma
- (2012) Ralf Küppers et al. JOURNAL OF CLINICAL INVESTIGATION
- Surveillance Computed Tomography Imaging and Detection of Relapse in Intermediate- and Advanced-Stage Pediatric Hodgkin's Lymphoma: A Report From the Children's Oncology Group
- (2012) Stephan D. Voss et al. JOURNAL OF CLINICAL ONCOLOGY
- HIV Status Does Not Influence Outcome in Patients With Classical Hodgkin Lymphoma Treated With Chemotherapy Using Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine in the Highly Active Antiretroviral Therapy Era
- (2012) Silvia Montoto et al. JOURNAL OF CLINICAL ONCOLOGY
- Dose-Intensification in Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD14 Trial
- (2012) Bastian von Tresckow et al. JOURNAL OF CLINICAL ONCOLOGY
- Routine Bone Marrow Biopsy Has Little or No Therapeutic Consequence for Positron Emission Tomography/Computed Tomography–Staged Treatment-Naive Patients With Hodgkin Lymphoma
- (2012) Tarec Christoffer El-Galaly et al. JOURNAL OF CLINICAL ONCOLOGY
- Gonadal Function and Fertility in Survivors After Hodgkin Lymphoma Treatment Within the German Hodgkin Study Group HD13 to HD15 Trials
- (2012) Karolin Behringer et al. JOURNAL OF CLINICAL ONCOLOGY
- Hodgkin's lymphoma in adults
- (2012) William Townsend et al. LANCET
- Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial
- (2012) Andreas Engert et al. LANCET
- Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphoma
- (2011) B. Boll et al. BLOOD
- A retrospective multicenter analysis of elderly Hodgkin lymphoma: outcomes and prognostic factors in the modern era
- (2011) A. M. Evens et al. BLOOD
- Prognostic value of interim FDG PET/CT in Hodgkin’s lymphoma patients treated with interim response-adapted strategy: comparison of International Harmonization Project (IHP), Gallamini and London criteria
- (2011) Pierre-Yves Le Roux et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Molecular Pathogenesis of Hodgkin's Lymphoma: Increasing Evidence of the Importance of the Microenvironment
- (2011) Christian Steidl et al. JOURNAL OF CLINICAL ONCOLOGY
- Second Cancer Risk After Chemotherapy for Hodgkin's Lymphoma: A Collaborative British Cohort Study
- (2011) Anthony J. Swerdlow et al. JOURNAL OF CLINICAL ONCOLOGY
- ABVD versus BEACOPP for Hodgkin's Lymphoma
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose Salvage Is Planned
- (2011) Simonetta Viviani et al. NEW ENGLAND JOURNAL OF MEDICINE
- ABVD Alone versus Radiation-Based Therapy in Limited-Stage Hodgkin's Lymphoma
- (2011) Ralph M. Meyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Establishment of a UK-wide network to facilitate the acquisition of quality assured FDG–PET data for clinical trials in lymphoma
- (2010) S. F. Barrington et al. ANNALS OF ONCOLOGY
- Evaluation of interim PET response criteria in paediatric Hodgkin's lymphoma--results for dedicated assessment criteria in a blinded dual-centre read
- (2010) C. Furth et al. ANNALS OF ONCOLOGY
- BEACOPP chemotherapy is a highly effective regimen in children and adolescents with high-risk Hodgkin lymphoma: a report from the Children's Oncology Group
- (2010) K. M. Kelly et al. BLOOD
- Phase 2 study of BACOPP (bleomycin, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in older patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)
- (2010) T. V. Halbsguth et al. BLOOD
- Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses
- (2010) Andrea Gallamini et al. BRITISH JOURNAL OF HAEMATOLOGY
- Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma
- (2010) Sally F. Barrington et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Long-Term Survival Among Patients With Hodgkin's Lymphoma Who Developed Breast Cancer: A Population-Based Study
- (2010) Michael T. Milano et al. JOURNAL OF CLINICAL ONCOLOGY
- Intensified Chemotherapy and Dose-Reduced Involved-Field Radiotherapy in Patients With Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD11 Trial
- (2010) Hans Theodor Eich et al. JOURNAL OF CLINICAL ONCOLOGY
- Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma
- (2010) Andreas Engert et al. NEW ENGLAND JOURNAL OF MEDICINE
- State-of-the-art Issues in Hodgkin’s Lymphoma Survivorship
- (2010) Shrujal S. Baxi et al. Current Oncology Reports
- The UK national breast cancer screening programme for survivors of Hodgkin lymphoma detects breast cancer at an early stage
- (2009) S J Howell et al. BRITISH JOURNAL OF CANCER
- Survival after Hodgkin lymphoma
- (2009) Olav Favier et al. CANCER
- Hodgkin lymphoma in the elderly: A clinical review of treatment and outcome, past, present and future
- (2009) S.J. Proctor et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0
- (2009) Ronald Boellaard et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Escalated-Dose BEACOPP in the Treatment of Patients With Advanced-Stage Hodgkin's Lymphoma: 10 Years of Follow-Up of the GHSG HD9 Study
- (2009) Andreas Engert et al. JOURNAL OF CLINICAL ONCOLOGY
- Second Neoplasms in Survivors of Childhood Cancer: Findings From the Childhood Cancer Survivor Study Cohort
- (2009) Anna T. Meadows et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Comparison of the Stanford V Regimen and ABVD in the Treatment of Advanced Hodgkin's Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244
- (2009) Peter J. Hoskin et al. JOURNAL OF CLINICAL ONCOLOGY
- ABVD Compared With BEACOPP Compared With CEC for the Initial Treatment of Patients With Advanced Hodgkin's Lymphoma: Results From the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial
- (2009) Massimo Federico et al. JOURNAL OF CLINICAL ONCOLOGY
- 18F-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients
- (2009) M. Weiler-Sagie et al. JOURNAL OF NUCLEAR MEDICINE
- On the Added Value of Baseline FDG-PET in Malignant Lymphoma
- (2009) Henriette Quarles van Ufford et al. MOLECULAR IMAGING AND BIOLOGY
- Isolated neutropenia during ABVD chemotherapy for Hodgkin lymphoma does not require growth factor support
- (2008) Jyoti Nangalia et al. LEUKEMIA & LYMPHOMA
- The conundrum of hodgkin lymphoma nodes: To be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelines
- (2008) Theodore Girinsky et al. RADIOTHERAPY AND ONCOLOGY
- How Is Hodgkin Lymphoma in Pregnancy Best Treated?
- (2008) V. Bachanova et al. Hematology-American Society of Hematology Education Program
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search